Patent Yard Sign in
Canadian application, no grantCanada

New amidinobenzylamine derivatives and their use as thrombin inhibitors

CA 2355792 A1 · Owner: Inghardt, Tord · Inventors: Nystrom, Jan-Erik; Inghardt, Tord

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

There is provided compounds of formula (I) wherein R1 R2 Y, R3 and R4 have , meanings given in the description which are useful as or as prodrugs of, competitive inhibitors of trypsin-like proteases such as thrombin, and in , particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 13, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 13, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 13, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 13, 2000
GrantedNo grant recorded
Term endedJanuary 13, 2020
Patent numberCA 2355792 A1
Classification (IPC)C07K5/06 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedJan 13, 2000Term endedJan 13, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.